ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

New Ultrasound Technique For Hard To Diagnose Cysts

June 29, 2001

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI

August 15, 1986

NCCS Changes Web Domain; NCCN Plans Clinical Trials Network

June 7, 2002

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

July 12, 1991

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986